Search Within

Julie Goodfriend

Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Advanced Practice Providers (2)
  6. Lymphoma (2)

More Groups

People
  1. Anthony Mato (7)
  2. Lindsey Roeker (7)
  3. Colleen Dorsey (5)
  4. Andrew Zelenetz (2)
  5. Isaac Deonarine Jr. (2)
  6. Katherine Whitaker (2)

More People

Years
  1. 2020 (2)
  2. 2019 (5)
Publications
  1. Blood (2)
  2. Leukemia and Lymphoma (2)
  3. Blood Advances (1)
  4. Hematological Oncology (1)
  5. JAMA Network Open (1)
Publishers
  1. American Society of Hematology (3)
  2. Taylor & Francis Group (2)
  3. American Medical Association (1)
  4. Wiley Blackwell (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL)
    Meeting Abstract

    Mato, A.; Roeker, L.; Eyre, T.; Ujjani, C.; Lamanna, N.; Hill, B.; Barr, P.; Lansigan, E.; Cheson, B. D.; Yazdy, M.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Hypertension in ibrutinib-treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Yazdy, M.; Gashonia, L.; Narkhede, M.; Goodfriend, J.; Rhodes, J.; Kennard, K.; Dorsey, C.; Sarmasti, L.; Calivo, K.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Toxicities and outcomes of acalabrutinib-treated patients with chronic lymphocytic leukemia: A retrospective analysis of real world patients
    Meeting Abstract

    Yazdy, M. S.; Mato, A. R.; Roeker, L. E.; Jarral, U.; Ujjani, C. S.; Shadman, M.; Skarbnik, A.; Whitaker, K. J.; Deonarine, I.; Kabel, C. C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Efficacy of therapies following venetoclax discontinuation in CLL: Focus on B-cell receptor signal transduction inhibitors and cellular therapies
    Meeting Abstract

    Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Jacobs, R.; Hill, B. T.; Lamanna, N.; Brander, D. M.; Shadman, M.; Ujjani, C.; Yazdy, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Hypertension in patients treated with ibrutinib for chronic lymphocytic leukemia
    Journal Article

    Roeker, L. E.; Sarraf Yazdy, M.; Rhodes, J.; Goodfriend, J.; Narkhede, M.; Carver, J.; Mato, A.
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Hypertension (HTN) in patients (pts) treated with ibrutinib (IBR) for chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Sarraf Yazdy, M.; Roeker, L.; Gashonia, L.; Goodfriend, J.; Narkhede, M.; Rhodes, J.; Kennard, K.; Morse, H.; Dorsey, C.; Battiato, K.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL
    Journal Article

    Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Nabhan, C.; Lamanna, N.; Hill, B. T.; Brander, D. M.; Barr, P. M.; Lansigan, F.; Cheson, B. D.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save